Sign Up to like & get
recommendations!
0
Published in 2024 at "Drug Development and Industrial Pharmacy"
DOI: 10.1080/03639045.2024.2409167
Abstract: Abstract Background Canagliflozin (CFZ) is broadly implicated for the management of type 2 diabetes mellitus. Unfortunately, it has low oral bioavailability due to poor solubility behavior and restricted membrane permeability. Objective The current work focuses…
read more here.
Keywords:
niosomes enhanced;
anti diabetic;
drug;
cfz ... See more keywords